Recruiting Atrial Fibrillation Studies in Tupelo
About Atrial Fibrillation Clinical Trials in Tupelo
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in Tupelo, MS. These studies are seeking a combined 165 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Tupelo — FAQ
Are there atrial fibrillation clinical trials in Tupelo?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in Tupelo, MS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tupelo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tupelo research site will contact you about next steps.
Are clinical trials in Tupelo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tupelo studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in Tupelo are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated July 13, 2026 from ClinicalTrials.gov